There is a distinct correlation between the concentration of sugar in the blood level of C level occurrence of diabetic foot syndrome. Treatment with drugs that eliminate insulinrezistentnost in Russia currently applies only in a small number of patients, in most cases, surgical treatment of diabetic foot. The search for new and effective methods of sustained therapeutic effect, more cost-effective and devoid of side effects, effects on the body remains relevant. One of these methods may be intravenous laser irradiation of blood with frequency λ=532 nm, this study confirms the effectiveness of its application. As shown by the experimental data, to the use of intravenous laser blood irradiation intravenous laser ir-radiation of blood indicators of glucose in the study and control groups was higher than normal. After the intra-venous laser irradiation of blood these figures were significantly reduced in the intervention group and the con-trol group showed a tendency to preserve the performance on the data at the beginning of the study. The study suggests that the inclusion of therapy intravenous laser irradiation of blood "blue" laser with a wavelength of 532 nm in patients with diabetic foot has a positive impact on the index of blood glucose. The foregoing gives rise to the following conclusions: in patients with diabetic foot syndrome was a significant in-crease in blood glucose therapy in the form of intravenous laser irradiation of blood "blue" laser with a wave-length of 532 nm significantly reduces the level of glucose
diabetes, diabetic foot, a blue laser.
1. Balabolkin M.I. Diabetologiya. M.: Meditsina, 2000.
2. Young M.J. Classification of ulcers and its relevance to management. In: A.J.M. Boulton, H. Connor, P. Canavagh. The Diabetic Foot (3d ed). Wiley 2000, S. 61-72.
3. Dedov I.I. Novye tekhnologii v diagnostike i lechenii patologii pochek pri sakharnom diabete. Materialy Vserossiyskogo kongressa «Diabet i pochki». M., 2009, S. 25-28.
4. Dibirov M.D., Briskin B.S. Khirurgicheskoe lechenie oslozhneniy diabeticheskoy angiopatii. M.. 2001, 321s.
5. Amos A.F., McCarty D.G., Zimmet P. The rising global burden of diabetes and its complications: es-timates and projections to the year 2010. Diabet Med. 1997. 14: (Suppl) 5. S. 1-85.
6. Armstrong D.G., Frykberg R.G. Classifying diabetic foot surgery: toward a rational definition. Diabet Med. 2003. V. 20. P. 329-331.
7. Armstrong D.G., Lavery L.A. Negative pressure Wound after parcial diabetic amputation: a multicen-tre, randomized controlled trial. The Lancet. 2005. V. 366. P. 1704-1710.
8. Banis J.C. Glabrous skin gafts for plantar defects. Foot Ancle Cin (USA). 2001. V.6. № 4. P. 827-837.
9. Boulton A.J., Vinik A.I., Arezzo J.C. Diabetic neuropathies. Diabetes Care. 2005. V. 28. P. 956-962.
10. Bowker J., Pfeifer M. The diabetic foot (Eds.). 6th edition. Mosby, 2001.
11. Bokeriya L.A., Gudkova R.G. Bolezni i vrozhdennye anomalii sistemy krovoobrashcheniya. Serdechno-sosudistaya khirurgiya 2005. M.: NTsSSKh im. A.N. Bakuleva RAMN, 2006. 114 c.
12. Briskin B.S., Proshin A.V. Oslozhnennyy sindrom diabeticheskoy stopy: patogenez, diagnostika i lechenie v pozhilom i starcheskom vozraste. Klinicheskaya gerontologiya. 2004. № 1. S. 33-40.
13. Kokov L.S., Zelenov M.A., Udovichenko A.E. Angiograficheskaya diagnostika, ballonnaya angioplastika i stentirovanie u bol´nykh s diabeticheskoy stopoy. Angiol i sosud khi. 2002. T. 8. № 4. S. 25-32.
14. Mezhdunarodnoe soglashenie po diabeticheskoy stope. M.: Bereg, 2000. 96 s.
15. Obraztsov A.V., Kokhan E.P., Zavarina I.K. Patogeneticheskie aspekty operatsii revaskulyariziruyushchey osteotrepanatsii. Angiol i sosud khir. 2000. T. 6. №1. S. 18-21.
16. Pokrovskiy A.V., Dan V.N., Chupin A.V. Vazaprostan (prostaglandin E1) v kompleksnom lechenii bol´nykh s ishemicheskoy diabeticheskoy stopoy. Angiol i sosud khir. 2000. T. 6. №2. S. 63-72.
